Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.75454 | 32 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.73627 | 32 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.73332 | 32 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.65262 | 31 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.64393 | 30 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.82511 | 33 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.80844 | 33 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.7135 | 32 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.71967 | 33 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.70715 | 32 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.85843 | 38 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.67915 | 31 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.73467 | 32 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.72225 | 32 |